Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001723805-18-000001
Filing Date
2018-08-28
Accepted
2018-08-28 16:55:52
Documents
1
Effectiveness Date
2018-08-28
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8547
  Complete submission text file 0001723805-18-000001.txt   9606
Mailing Address 1825 K STREET NW SUITE 520 WASHINGTON DC 20006
Business Address 1825 K STREET NW SUITE 520 WASHINGTON DC 20006 202-223-7002
Chase Therapeutics Corp (Filer) CIK: 0001723805 (see all company filings)

EIN.: 815113723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-320230 | Film No.: 181042195